| | DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Basic information |
| Product Name: | DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) | | Synonyms: | Dihydrocodeine Bitartrate CII (200 mg);4,5-alpha-epoxy-3-methoxy-17-methyl-morphinan-6-alpha-otartrate(1:1);4,5alpha-epoxy-3-methoxy-17-methyl-morphinan-6alpha-otartrate(1:1)(sal;df118;dihydrocodeineacidtartrate;dihydrocodeinebitartrate;dihydro-codeintartrate(1:1);DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) | | CAS: | 5965-13-9 | | MF: | C22H29NO9 | | MW: | 451.46696 | | EINECS: | 2277477 | | Product Categories: | | | Mol File: | 5965-13-9.mol |  |
| | DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Chemical Properties |
| Melting point | 192 °C (decomp) | | solubility | Freely soluble in water, sparingly soluble in alcohol, practically insoluble in cyclohexane. | | CAS DataBase Reference | 5965-13-9 |
| | DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Usage And Synthesis |
| Chemical Properties | White or almost white, crystalline powder. | | Originator | Bicodein,Uquifa | | Uses | Opioid receptor agonist; analgesic | | Manufacturing Process | The codein was reduced by hydrogen in the presence catalyst Pt (or Pd, or Ni)
and 7,8-dihydrocodein was obtained.
To the 7,8-dihydrocodein tartaric acid was added and mixed, in the result 7,8-
dihydrocodein bitartrate was obtained. | | Therapeutic Function | Antitussive, Narcotic analgesic |
| | DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Preparation Products And Raw materials |
|